1. Role of the Board
The Board is collectively responsible for the governance of Life Without Debt Ltd and for ensuring the Company pursues its charitable purposes in a lawful, effective and accountable manner. In particular, the Board:
- sets and safeguards the Company's mission, strategy, values and risk appetite;
- appoints, supports, oversees and (if necessary) removes the CEO;
- approves annual budgets, key policies and material transactions;
- monitors performance against strategy, budget and risk indicators;
- oversees compliance with the Corporations Act, the ACNC Act, the Governance Standards and all applicable laws;
- ensures the Company is accountable to its Members, beneficiaries, donors and the public.
2. Composition
- 2.1 The Board comprises a minimum of 3 and a maximum of 9 Directors as specified in the Constitution.
- 2.2 The Board aspires to a majority of Independent Directors and, in any case, an Independent Chair.
- 2.3 Directors are expected to bring, collectively, expertise in:
- charity and not-for-profit governance;
- Australian consumer credit / financial services / NCCP law;
- terminal-illness / palliative-care / medical practice;
- legal (charity law, credit law, privacy);
- finance and audit (CA/CPA);
- fundraising, marketing or communications;
- lived experience of terminal or serious illness in a family member.
- 2.4 The Board reviews its composition against this skills matrix annually.
- 2.5 Founding Directors and Co-founders. Laurence Hugo (Founding Director & Co-founder / CEO) and Lisa Hugo (Business Development Director & Co-founder) are the founding Directors of the Company. Their appointments are recorded in the Constitution and the ASIC Form 201 lodgement.
- 2.6 Board-Appointed Advisors (not Directors). The Board has appointed the following external advisors, who attend Board meetings in an advisory, non-voting capacity and are not Directors of the Company:
- Prof Deen Sanders OAM (Worimi Giparr) — Board-Appointed Legal Advisor. Founder, Think.Know.Do.; Adjunct Professor, University of Newcastle Law School; External Special Counsel, Deloitte Access Economics; Co-Chair, WEF Global Future Council on Natural Capital; Director of Australian Sustainable Finance Institute, Living Country Group and Indigenous Systems Knowledge Collective.
- Carla Oliver CPA, CIMA, BA(Hons) Bus. — Board-Appointed CFO Advisor. Principal, CoSai CFO Services.
- 2.7 Advisor appointments are recorded in the First Directors' Resolutions and the Register of Interests. Advisors are subject to confidentiality obligations equivalent to Directors, disclose interests in an equivalent form (see the Conflicts of Interest Policy and Register of Interests), and do not vote on Board matters. Advisor appointments may be revoked by ordinary Board resolution.
3. Chair
- 3.1 The Chair is appointed by the Directors from among the Independent Directors.
- 3.2 The Chair leads Board meetings, sets meeting agendas jointly with the CEO and Company Secretary, ensures effective participation by all Directors, and represents the Company externally where appropriate.
4. Meetings
- 4.1 The Board meets at least four (4) times per financial year (Constitution clause 21.1), with additional meetings as required.
- 4.2 Notice of each meeting, together with the agenda and papers, is circulated at least 5 business days in advance except in urgent circumstances.
- 4.3 Quorum: majority of Directors then in office, including at least one Independent Director.
- 4.4 Every meeting includes standing items: Conflicts declarations; Financial position; Case-work summary and Direct Relief report; Compliance report; and Risk register update.
- 4.5 Minutes are drafted by the Company Secretary and confirmed at the next meeting.
5. Decision authorities — Delegated Authorities Schedule (DAS)
The following schedule sets out, for each category of decision, the level of authority required. Any matter not listed defaults to the Board. Dollar figures are Australian dollars, GST-inclusive where applicable, and refer to single-transaction value (aggregated over a rolling 12 months for the same counterparty). The Schedule may be updated only by Board resolution and is reproduced in full in the Delegation Register maintained by the Company Secretary.
5.1 Strategy and mission
| Matter | Authority | Notes / evidence required |
| Set, alter, or reaffirm strategic plan | Board resolution | Reviewed annually at the strategic-planning day |
| Alter charitable purposes clause of the Constitution | Members' Special Resolution (75%) + ACNC no-objection + ATO no-objection | Alteration lock, Constitution cl.30 |
| Adopt or amend other Constitution clauses | Members' Special Resolution (75%) | s.136(2) Corporations Act |
| Wind up the Company | Members' Special Resolution | Constitution cl.26–29 |
5.2 Governance, policies, and risk
| Matter | Authority | Notes / evidence required |
| Adopt or amend a governance policy | Board resolution | Policy owner reports to Audit & Risk sub-committee |
| Approve annual Risk Register & risk appetite statement | Board resolution (on A&R recommendation) | Refresh at least annually |
| Approve annual Compliance Calendar | Board resolution | Maintained by Company Secretary |
| Approve strategic risk mitigation projects > $10,000 | Board resolution | Business case required |
5.3 Financial — expenditure, contracts, and reserves
| Matter | Authority | Notes / evidence required |
| Approve annual budget | Board resolution | Before 30 June each year |
| Approve within-budget operating expenditure ≤ $2,000 per item | CEO | Single-signatory; recorded in the accounting system |
| Approve within-budget operating expenditure $2,001 – $10,000 per item | CEO + one Director (co-signatory) | Dual signatory; email approval sufficient |
| Approve within-budget operating expenditure > $10,000 per item | Board resolution | May be circular resolution |
| Approve any over-budget item (any amount) | Board resolution | Variance analysis attached |
| Enter into a contract with a term > 12 months or unliquidated liability > $20,000 | Board resolution | Chair signs on Board's behalf |
| Set or amend the target reserves range (per Reserves Policy) | Board resolution | Chair of A&R sub-committee reports quarterly |
| Draw down reserves | Board resolution | Reserves Policy trigger required |
| Borrow money or grant a security interest | Board resolution + Constitution cl.4 test | Note that PBI status materially constrains borrowing |
| Give a guarantee or indemnity | Board resolution | Rare; expected to be nil in Year 1 |
5.4 Beneficiary services — direct relief, direct debt payoff, and hardship-negotiation
| Matter | Authority | Notes / evidence required |
| Approve a beneficiary application (eligibility & intake) | Beneficiary Liaison Officer + CEO (dual sign-off) | Documentary evidence per intake pack retained |
| Direct financial relief payment ≤ $1,500 per beneficiary per event | CEO | Direct Relief Policy cap; retained on file |
| Direct financial relief payment $1,501 – $5,000 per beneficiary per event | CEO + one Director (co-sign) | Dual signatory; A&R sub-committee informed |
| Direct financial relief payment > $5,000 per beneficiary per event | Board resolution | Rare exception |
| Direct debt payoff to a creditor ≤ $5,000 | CEO + one Director (co-sign) | Direct Relief Policy Section 4 controls |
| Direct debt payoff to a creditor $5,001 – $15,000 | Board resolution | Individual beneficiary cap |
| Direct debt payoff to a creditor > $15,000 | Board resolution + external professional advice (financial counsellor or solicitor) | Very rare; exceptional-case only |
| Aggregate direct relief to a beneficiary over a rolling 12 months | Cap: $15,000 per beneficiary — Board resolution to exceed | Direct Relief Policy §5 |
| Aggregate direct relief expenditure per financial year | Cap: 25% of Y1 total revenue — Board resolution to exceed | Direct Relief Policy §6 |
5.5 People — hire, remuneration, and termination
| Matter | Authority | Notes / evidence required |
| Appoint, remunerate or terminate the CEO | Board resolution (CEO recused) | Chapter 2E arm's-length terms (s.210) |
| Appoint or terminate any Director-related party (e.g. spouse/child of a Director) | Board resolution (interested Director recused) | Chapter 2E + Related-Party Policy |
| Appoint or dismiss any other employee | CEO | Within approved staffing budget |
| Approve total remuneration for any employee > $120,000 p.a. | Board resolution | N&R sub-committee reviews |
| Engage a contractor for a fee > $10,000 in a single engagement | Board resolution | Competitive-quote required (min. 2 quotes) unless Board waives |
| Bind D&O, PI, or public liability insurance renewal | CEO within Board-approved parameters | Broker report to Board annually |
5.6 Related parties (Chapter 2E)
| Matter | Authority | Notes / evidence required |
| Any financial benefit to a related party | Board resolution (interested Directors recused); Members' resolution required unless s.210 arm's-length terms apply | Related-Party Policy §2; register entry required |
| Renewal of CoSai CFO Services engagement (Year 2 and beyond) | Board resolution + minimum 2 external competitive quotes | Rebuts inference that arm's-length terms are absent |
| Any donation by a Director-related entity > $10,000 | Note-only to Board; no approval required | Recorded in the Register of Donors |
5.7 Banking and treasury
| Matter | Authority | Notes / evidence required |
| Open or close a bank account (including the Gift Fund account) | Board resolution | Dual signatories required by Constitution cl.19 |
| Payments ≤ $2,000 | Any authorised signatory (single) | Operating account only; never Gift Fund |
| Payments > $2,000 | Two authorised signatories | Applies to operating and Gift Fund accounts |
| Investment of surplus funds (term deposit / cash management) | Board resolution | Only in APRA-regulated ADIs; no equities |
5.8 Fundraising, communications, and disclosures
| Matter | Authority | Notes / evidence required |
| Approve fundraising strategy and calendar | Board resolution (annual) | State fundraising licence compliance confirmed |
| Accept a major gift > $50,000 or any conditional gift | Board resolution | Gift Acceptance Policy applies (Year 2 build) |
| Sign the Annual Information Statement (AIS) for lodgement with ACNC | CEO + Chair (dual sign) | Board reviews draft AIS before lodgement |
| Media statement or press release on operational matters | CEO | Chair notified for material matters |
| Media statement or press release on governance or regulatory matters | Chair (with CEO input) | Media Kit boilerplate applied |
| Public submission to a parliamentary inquiry or regulator consultation | Board resolution | Draft circulated to full Board |
5.9 Beneficiary data, privacy, and IT
| Matter | Authority | Notes / evidence required |
| Notify a "notifiable data breach" to the OAIC | CEO on Chair's authority (with Company Secretary) | Privacy Act 1988 Part IIIC · within 30 days of awareness |
| Approve any transfer of beneficiary data offshore | Board resolution | APP 8 compliance required; expected to be nil |
| Sign any data-sharing arrangement with a referral partner | Board resolution | Standing template in Beneficiary Intake Pack |
| Approve annual cyber-security review | Board resolution (on A&R recommendation) | Aligned with the ACSC Essential Eight, at maturity level suitable for organisation size |
6. Committees (sub-committee structure)
The Board establishes the following standing sub-committees. Each has a written Terms of Reference approved by the Board, and reports to the Board at each ordinary meeting. Sub-committees exist to give focused oversight in specialised areas — they do not have independent decision-making authority except where expressly delegated by the DAS at §5.
6.1 Audit & Risk Committee (A&R)
| Purpose | Oversight of financial reporting, external audit, internal control, the Risk Register, compliance monitoring, and IT security posture. Reviews all financial statements before Board sign-off and manages the auditor relationship. |
| Composition | Minimum 2 Directors; Chair must be an independent Director with a professional accounting or audit qualification (CA / CPA). CEO and CFO attend by invitation. |
| Meeting cadence | Quarterly (aligned with Board cycle) plus one extraordinary meeting before AIS lodgement and one before annual audit sign-off. |
| Key annual deliverables | (a) recommend appointment of external auditor; (b) approve internal audit plan (if any); (c) recommend Risk Register update to Board; (d) recommend annual Compliance Calendar; (e) review whistleblower reports and outcomes. |
6.2 Nominations & Remuneration Committee (N&R)
| Purpose | Recommends Director appointments, oversees the Board skills-matrix review, and recommends executive remuneration. Manages the Director recruitment process (see the Director Recruitment Brief). |
| Composition | Minimum 2 Directors; Chair of the Board is Chair of this sub-committee ex officio. Majority independent. |
| Meeting cadence | At least twice per year, plus ad hoc for candidate interviews. |
| Key annual deliverables | (a) refresh Board skills matrix; (b) succession plan for Chair and CEO; (c) benchmarked CEO remuneration recommendation; (d) new-Director induction plan. |
6.3 Beneficiary Services & Case Review Committee (BSC)
| Purpose | Quality assurance for the Company's core operating output. Reviews a randomised sample of closed cases each quarter; reviews all cases in which a direct-relief cap was invoked or exceeded; oversees relationships with referring financial-counselling and clinical partners; recommends changes to the Direct Relief Policy and Beneficiary Intake Pack. |
| Composition | Minimum 2 Directors, including one with clinical (palliative care or oncology) expertise, and one with financial counselling / consumer credit expertise. May include an external non-Director advisor with lived experience, appointed on merit. |
| Meeting cadence | Quarterly. |
| Key annual deliverables | (a) case-quality report to Board; (b) beneficiary-outcome dashboard; (c) recommendations on Direct Relief cap settings; (d) recommendations on referral-partner arrangements. |
Year 2 review: the Board will consider whether a dedicated Fundraising & Communications sub-committee is warranted, and whether a Credit Licensing sub-committee should be established to prepare for a potential Year-2/3 ACL application.
7. Delegations to the CEO
The Board delegates to the CEO all authorities necessary to run the Company's day-to-day operations within the approved annual budget, this Charter, the Constitution, and the Delegated Authorities Schedule at §5. Specifically, the CEO is authorised to:
- execute the Company's strategic and operational plans within the approved budget;
- hire and dismiss employees within the staffing budget (except related parties, which require Board resolution);
- approve operating expenditure within the DAS limits set at §5.3;
- approve beneficiary intakes with the Beneficiary Liaison Officer (dual sign-off) and direct-relief payments within the DAS limits at §5.4;
- sign Company documents that do not require a Board resolution;
- bind renewals of D&O, PI, and public liability insurance within Board-approved parameters;
- speak on behalf of the Company on operational matters, subject to the media protocols at §5.8; and
- generally do all things necessary and incidental to the day-to-day management of the Company.
The CEO's authority is subject to (i) the reserved matters expressly retained by the Board at §5 above; (ii) the general duties of a director and officer under the Corporations Act; and (iii) the Company's policies. The written Delegation Register maintained by the Company Secretary records all delegations and is reviewed annually by the Board.
8. Director induction and ongoing development
- Each new Director receives, on appointment: the Constitution; this Board Charter; all governance policies; the current strategic plan and budget; the most recent financial statements; the ACNC's Governance for good guide; and a copy of the current Conflicts Register.
- Each Director undertakes not less than 4 hours of governance / regulatory professional development each year.
- The Chair conducts an induction meeting with each new Director within 30 days of appointment.
9. Evaluation
The Board conducts an annual evaluation of: (a) its own effectiveness; (b) individual Director performance (through peer feedback); (c) the effectiveness of committees; and (d) the CEO. An external facilitator is engaged for a full board evaluation at least every three years.
10. Access to information and advice
Directors are entitled to reasonable access to Company information and, at the Company's cost with prior notice to the Chair, to independent professional advice necessary to discharge their duties.
In addition, Directors have direct access to the Board-Appointed Advisors (Legal Advisor and CFO Advisor — see clause 2.6) for advice on matters within their respective competencies. Where an Advisor's advice would be given at the Company's cost beyond the scope of the standing advisory engagement, the Chair's prior notice under this clause applies.